| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1601-0825.2011.01793.X |
| P698 | PubMed publication ID | 21382140 |
| P50 | author | Martin Thornhill | Q38639900 |
| Lauren L. Patton | Q44152400 | ||
| P2093 | author name string | S Porter | |
| P B Lockhart | |||
| K Hull | |||
| M S Greenberg | |||
| V Sankar | |||
| A R Kerr | |||
| D Vidovic Juras | |||
| V Hearnden | |||
| P2860 | cites work | Recommendations for the pharmacological management of neuropathic pain: an overview and literature update | Q24616897 |
| Palifermin for oral mucositis after intensive therapy for hematologic cancers | Q28298574 | ||
| Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. | Q31144647 | ||
| Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid | Q31943869 | ||
| Locally delivered antimicrobials for the treatment of chronic periodontitis | Q33188534 | ||
| Nucleotide excision repair pathway genes and oral premalignant lesions | Q33288021 | ||
| Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions | Q33328405 | ||
| Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data | Q33510238 | ||
| Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions | Q33943542 | ||
| The human oral microbiome | Q34127792 | ||
| A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation | Q34190340 | ||
| A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact | Q37718044 | ||
| Medical management of trigeminal neuropathic pains | Q37738909 | ||
| Future directions in neuropathic pain therapy: closing the translational loop | Q37757932 | ||
| The management of mucous membrane pemphigoid and pemphigus | Q37769572 | ||
| Treatment of primary Sjögren syndrome: a systematic review | Q37776086 | ||
| Use of a mucoadhesive disk for relief of dry mouth: a randomized, double-masked, controlled crossover study | Q39279081 | ||
| The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study | Q39301198 | ||
| Intercellular junctions of oral epithelium. I. Studies with freeze-fracture and tracing methods of normal rat keratinized oral epithelium | Q39392107 | ||
| A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjögren's syndrome | Q39400317 | ||
| Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis | Q42439928 | ||
| Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro | Q42479700 | ||
| bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study | Q42481800 | ||
| Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES) | Q42848254 | ||
| Recalcitrant pemphigus vulgaris responding to systemic tacrolimus | Q43001480 | ||
| Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial | Q43089511 | ||
| The permeability of oral leukoplakia | Q44530035 | ||
| Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia | Q44795378 | ||
| Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers | Q46302357 | ||
| Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib | Q46365845 | ||
| Topical application of photofrin for photodynamic diagnosis of oral neoplasms | Q46516844 | ||
| A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration | Q46596374 | ||
| In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients | Q46777579 | ||
| The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration | Q46907036 | ||
| Liposomes as drug carriers for oral ulcers | Q48306138 | ||
| Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. | Q51524649 | ||
| Gene therapy of salivary diseases. | Q51901775 | ||
| Immune mechanisms in oral lichen planus | Q34335173 | ||
| Oral mucosal disease: recurrent aphthous stomatitis | Q34686534 | ||
| Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis | Q34776705 | ||
| Thalidomide: a role in oral oncology? | Q34776883 | ||
| The pathogenesis of oral lichen planus | Q34793377 | ||
| Orotransmucosal drug delivery systems: a review | Q34996304 | ||
| The diagnosis and management of recurrent aphthous stomatitis: a consensus approach | Q35085161 | ||
| An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. | Q35911903 | ||
| Number II. Pemphigus vulgaris | Q36124161 | ||
| Probiotics: do they have a role in oral medicine and dentistry? | Q36161551 | ||
| Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis | Q36161959 | ||
| Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention | Q36173404 | ||
| A systematic review of placebo-controlled randomized clinical trials of treatments used in oral lichen planus. | Q36222141 | ||
| Topical analgesics in neuropathic pain | Q36264629 | ||
| The use of mucoadhesive polymers in buccal drug delivery | Q36267386 | ||
| Mucosal disease series. Number VI. Recurrent aphthous stomatitis | Q36359427 | ||
| Medications for neuropathic pain: current trends | Q36475074 | ||
| Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward | Q36508209 | ||
| Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs | Q36530971 | ||
| Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium | Q36674276 | ||
| Erythema multiforme and related disorders | Q36753920 | ||
| Advances in topical and systemic antifungals. | Q36790249 | ||
| Use of topical medication in orofacial neuropathic pain: a retrospective study. | Q37105825 | ||
| Distribution of anthocyanins delivered from a bioadhesive black raspberry gel following topical intraoral application in normal healthy volunteers | Q37182850 | ||
| Steriods in the treatment of lichen planus: a review | Q37357674 | ||
| Bacterial infections of the oral mucosa | Q37371873 | ||
| Oral mucosal fungal infections. | Q37371876 | ||
| Oral viral infections of adults | Q37371879 | ||
| Oral viral infections of children | Q37371883 | ||
| Targeted therapies in squamous cell carcinoma of the head and neck | Q37373573 | ||
| The oral mucosa as a therapeutic target for xerostomia | Q37385448 | ||
| Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists | Q37524952 | ||
| Calcineurin inhibitors in oral medicine | Q37616514 | ||
| Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update | Q37640153 | ||
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 73-84 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Oral Diseases | Q15724675 |
| P1476 | title | Local drug delivery for oral mucosal diseases: challenges and opportunities | |
| P478 | volume | 17 Suppl 1 |
| Q28087186 | Advanced drug delivery systems for local treatment of the oral cavity |
| Q35013217 | Affinity based multilayered polymeric self-assemblies for oral wound applications |
| Q52882017 | Aloin Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells. |
| Q51043354 | Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system. |
| Q37999475 | Biologics in oral medicine: ulcerative disorders |
| Q39102293 | Buccal drug delivery: what's new and what does the future hold? |
| Q39170783 | Comparison between self-formulation and compounded-formulation dexamethasone mouth rinse for oral lichen planus: a pilot, randomized, cross-over trial. |
| Q64251667 | Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria |
| Q55025431 | Effect of local application of curcumin and ornidazole gel in chronic periodontitis patients. |
| Q93004363 | Emerging Applications of Drug Delivery Systems in Oral Infectious Diseases Prevention and Treatment |
| Q90556964 | Full-Thickness Intraoral Mucosa Barrier Models for In Vitro Drug-Permeation Studies Using Microneedles |
| Q42159529 | Gelatin/carboxymethyl cellulose mucoadhesive films with lysozyme: Development and characterization |
| Q40125974 | In vitro behavior of poly-lactic-co-glycolic acid microspheres containing minocycline, metronidazole, and ciprofloxacin. |
| Q93151630 | Mucoadhesive Hybrid Polymer/Liposome Pastes Based on Modified Polysaccharides |
| Q38541845 | Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management |
| Q34784578 | Physical methods to promote drug delivery on mucosal tissues of the oral cavity |
| Q38733264 | Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin. |
| Q39398234 | Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer. |
| Q47355869 | Proniosomes derived niosomes: recent advancements in drug delivery and targeting. |
| Q38213101 | Report on World Workshops on Oral Medicine (WWOM) IV and V: research themes and citation impact: WWOM VI steering committee |
| Q36756072 | Semi-interpenetrating network (sIPN) gelatin nanofiber scaffolds for oral mucosal drug delivery |
| Q47772462 | The effect of saliva on the fate of nanoparticles |
| Q90086877 | The effect of the source and the concentration of polymers on the release of chlorhexidine from mucoadhesive buccal tablets |
| Q38025689 | Urban legends series: lichen planus |
| Q86825057 | [Topical pain therapy in oral mucositis: a systematic review] |
Search more.